Real stories Q&A: Geoff Parker on improving dementia diagnosis with MRI scans Meet Geoff Parker, Professor of Healthcare Engineering, Imaging and Enterprise at UCL in London, who discusses his dementia research. Meet Geoff Parker, Professor of Healthcare Engineering, Imaging and Enterprise at UCL in London, who discusses his dementia research. ... 28 March 2023
Research Honouring a couple affected by dementia for their contributions to dementia research We are delighted to announce that Carol and Stuart Jennings have become Vice-Presidents of Alzheimer’s Society. The couple have contributed a vast amount to the field of dementia research, and here we share some of their incredible achievements. We are delighted to announce that Carol and Stuart Jennings have become Vice-Presidents of Alzheimer’s Society. The couple have contributed a vast amount to the field of dementia research, and here we share some of their incredible achievements. ... 15 March 2023
Real stories Q&A: Kieren Egan on researching healthy ageing, dementia and caregivers Meet Kieren Egan, Senior Research Fellow at the University of Strathclyde. Meet Kieren Egan, Senior Research Fellow at the University of Strathclyde. ... 01 February 2023
News Tag: News. Alzheimer's Society comment on trial results of antipsychotic drug brexpiprazole for use in dementia agitation Phase III trial results revealed at Clinical Trials on Alzheimer's Disease conference in San Francisco. Read more
Real stories Researching microRNA to help improve diagnosis of Alzheimer’s and frontotemporal dementia Meet Joe Morgan, PhD student at the University of Salford. Meet Joe Morgan, PhD student at the University of Salford. ... 01 December 2022
Real stories Researching how best to change attitudes towards dementia among younger people Meet Esra Hassan, PhD student at Brighton and Sussex Medical School’s Centre for Dementia Studies. Meet Esra Hassan, PhD student at Brighton and Sussex Medical School’s Centre for Dementia Studies. ... 30 September 2022
News Tag: News. Progress with new Alzheimer’s drug lecanemab announced by manufacturers Eisai and Biogen Yesterday (27 September 2022), Eisai Co. Ltd. and Biogen announced top-line results for a major trial on the drug lecanemab in slowing down the progress of Alzheimer’s disease. Alzheimer's Society comments on this Alzheimer’s progression drug hope. Read more
News Tag: News. PM announces dementia mission in memory of Dame Barbara Windsor Today the Prime Minister Boris Johnson announced that he will be launching a new ‘national dementia mission’ in honour of the late Dame Barbara Windsor. Read more
Real stories Researching the antiviral immune system’s role in Alzheimer’s disease Meet Sophie Sanford, PhD student at the UK Dementia Research Institute, University of Cambridge. Meet Sophie Sanford, PhD student at the UK Dementia Research Institute, University of Cambridge. ... 29 July 2022
News Tag: News. £7.5 million collaboration with NIHR to fund early career researchers in dementia Alzheimer’s Society and NIHR announce a £7.5 million partnership to provide 45 brand new post-doctoral positions in dementia for NIHR Applied Research Collaborations. Read more
Research Tag: Research. Meet the researchers from our Dementia Research Leaders programme Learn about the researchers who are part of our Dementia Research Leaders programme, which supports early career researchers from biomedical, clinical and social science backgrounds. Read more
Information Tag: Information. Our Research Mission Statement Learn about Alzheimer's Society's new direction of travel for dementia research from 2022 to 2027. Read more